UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 46

Sortiert nach

Difficult-to-Treat Resistance in Gram-negative Bacteremia at 173 US Hospitals: Retrospective Cohort Analysis of Prevalence, Predictors, and Outcome of Resistance to All First-line Agents

Clinical infectious diseases, 2018-11, Vol.67 (12), p.1803-1814

2018

Link zum Volltext

Verfügbarkeit prüfen

Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals

The Lancet infectious diseases, 2021-02, Vol.21 (2), p.241-251

2021

Link zum Volltext

Verfügbarkeit prüfen

Procalcitonin-Guided Antibiotic Discontinuation and Mortality in Critically Ill Adults: A Systematic Review and Meta-analysis

Chest, 2019-06, Vol.155 (6), p.1109-1118

2019

Link zum Volltext

Verfügbarkeit prüfen

Cefiderocol and the Need for Higher-Quality Evidence: Methods Matter for Patients

Antimicrobial agents and chemotherapy, 2022-08, Vol.66 (8), p.e0076622-e0076622

2022

Link zum Volltext

Verfügbarkeit prüfen

Effect of 7 vs 14 Days of Antibiotics Among Afebrile Men With Urinary Tract Infection

JAMA : the journal of the American Medical Association, 2021-11, Vol.326 (20), p.2079

2021

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Efficacy Endpoints for a Phase IIb Study of a Respiratory Syncytial Virus Vaccine in Older Adults Using Patient-Reported Outcomes With Laboratory Confirmation

Value in health, 2020-02, Vol.23 (2), p.227-235

2020

Link zum Volltext

Verfügbarkeit prüfen

Analysis of US Food and Drug Administration new drug and biologic approvals, regulatory pathways, and review times, 1980-2022

Scientific reports, 2024-02, Vol.14 (1), p.3325-3325

2024

Link zum Volltext

Verfügbarkeit prüfen

Needs assessment for novel Gram-negative antibiotics in US hospitals: a retrospective cohort study

The Lancet infectious diseases, 2020-10, Vol.20 (10), p.1172-1181

2020

Link zum Volltext

Verfügbarkeit prüfen

Clinical Outcome Assessments: Conceptual Foundation—Report of the ISPOR Clinical Outcomes Assessment – Emerging Good Practices for Outcomes Research Task Force

Value in health, 2015-09, Vol.18 (6), p.741-752

2015

Link zum Volltext

Verfügbarkeit prüfen

Reporting of Drug Benefit in FDA-Approved Prescription Drug Labeling

Journal of general internal medicine : JGIM, 2020-01, Vol.35 (1), p.377-379

2020

Link zum Volltext

Verfügbarkeit prüfen

Communication of Nonefficacy Benefits of New Drugs Approved on the Basis of Noninferiority Trials Alone: Cohort Study of FDA and Sponsor Communication, 2011-2017

JAMA internal medicine, 2019-05, Vol.179 (5), p.719

2019

Link zum Volltext

Verfügbarkeit prüfen

Patient-Reported Outcome Assessments as Endpoints in Studies in Infectious Diseases

Clinical infectious diseases, 2016-08, Vol.63 (suppl 2), p.S52-S56

2016

Link zum Volltext

Verfügbarkeit prüfen

Clinician-Reported Outcome Assessments of Treatment Benefit: Report of the ISPOR Clinical Outcome Assessment Emerging Good Practices Task Force

Value in health, 2017, Vol.20 (1), p.2-14

2017

Link zum Volltext

Verfügbarkeit prüfen

Content validity and psychometric properties of the inFLUenza Patient-Reported Outcome Plus (FLU-PRO Plus©) instrument in patients with COVID-19

Quality of life research, 2023-06, Vol.32 (6), p.1645-1657

2023

Link zum Volltext

Verfügbarkeit prüfen

Perspectives of US Adults on Antimicrobial Trials With Noninferiority Designs

JAMA network open, 2023-05, Vol.6 (5), p.e2316297-e2316297

2023

Link zum Volltext

Verfügbarkeit prüfen

Informed Consent to Study Purpose in Randomized Clinical Trials of Antibiotics, 1991 Through 2011

JAMA internal medicine, 2017-10, Vol.177 (10), p.1452

2017

Link zum Volltext

Verfügbarkeit prüfen

Impact of respiratory syncytial virus disease on quality of life in adults aged ≥50 years: A qualitative patient experience cross‐sectional study

Influenza and other respiratory viruses, 2022-05, Vol.16 (3), p.462-473

2022

Link zum Volltext

Verfügbarkeit prüfen

Regulating Antibiotics in an Era of Resistance: The Historical Basis and Continued Need for Adequate and Well-Controlled Investigations

Annals of internal medicine, 2015-09, Vol.163 (5), p.386

2015

Link zum Volltext

Verfügbarkeit prüfen

Factor Analysis in Distinguishing Coronavirus Disease 2019 From Other Influenza-like Illness Using a Validated Patient-Reported Outcome Instrument FLU-PRO Plus: A Prospective Real-world Cohort Study

Medical care, 2023-05, Vol.61 (5), p.288

2023

Link zum Volltext

Verfügbarkeit prüfen

Using the Influenza Patient-reported Outcome (FLU-PRO) diary to evaluate symptoms of influenza viral infection in a healthy human challenge model

BMC infectious diseases, 2018-07, Vol.18 (1), p.353-353, Article 353

2018

Link zum Volltext

Verfügbarkeit prüfen

A Comparative Assessment of Approvals and Discontinuations of Systemic Antibiotics and Other Therapeutic Areas

Healthcare (Basel), 2023-06, Vol.11 (12), p.1759

2023

Link zum Volltext

Verfügbarkeit prüfen

External Validation of Difficult-to-Treat Resistance Prevalence and Mortality Risk in Gram-Negative Bloodstream Infection Using Electronic Health Record Data From 140 US Hospitals

Open forum infectious diseases, 2019-04, Vol.6 (4), p.ofz110-ofz110

2019

Link zum Volltext

Verfügbarkeit prüfen

Understanding the life experience of Barth syndrome from the perspective of adults: a qualitative one-on-one interview study

Orphanet journal of rare diseases, 2019-11, Vol.14 (1), p.243-243, Article 243

2019

Link zum Volltext

Verfügbarkeit prüfen

Immune and behavioral correlates of protection against symptomatic post-vaccination SARS-CoV-2 infection

Frontiers in immunology, 2024, Vol.15, p.1287504-1287504

2024

Link zum Volltext

Verfügbarkeit prüfen

Quality of life of HIV-negative, previously healthy individuals following cryptococcal meningoencephalitis

Scientific reports, 2021-02, Vol.11 (1), p.3673-3673, Article 3673

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 46

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(46)

Sprache

Englisch
(46)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(44)
Life Sciences & Biomedicine
(42)
Humans
(32)
Infectious Diseases
(16)
Anti-Bacterial Agents - Therapeutic Use
(12)
General & Internal Medicine
(11)
Male
(10)
Female
(9)
Influenza
(9)
Medicine, General & Internal
(9)
Aged
(8)
Clinical Trials
(8)
Immunology
(8)
Microbiology
(8)
Middle Aged
(8)
Health Care Sciences & Services
(7)
Adult
(6)
Antibiotics
(6)
Health Policy & Services
(6)
Adults
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Difficult-to-Treat Resistance in Gram-negative Bacteremia at 173 US Hospitals: Retrospective Cohort Analysis of Prevalence, Predictors, and Outcome of Resistance to All First-line Agents

Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals

Procalcitonin-Guided Antibiotic Discontinuation and Mortality in Critically Ill Adults: A Systematic Review and Meta-analysis

Cefiderocol and the Need for Higher-Quality Evidence: Methods Matter for Patients

Effect of 7 vs 14 Days of Antibiotics Among Afebrile Men With Urinary Tract Infection

Evaluation of Efficacy Endpoints for a Phase IIb Study of a Respiratory Syncytial Virus Vaccine in Older Adults Using Patient-Reported Outcomes With Laboratory Confirmation

Analysis of US Food and Drug Administration new drug and biologic approvals, regulatory pathways, and review times, 1980-2022

Needs assessment for novel Gram-negative antibiotics in US hospitals: a retrospective cohort study

Clinical Outcome Assessments: Conceptual Foundation—Report of the ISPOR Clinical Outcomes Assessment – Emerging Good Practices for Outcomes Research Task Force

Reporting of Drug Benefit in FDA-Approved Prescription Drug Labeling

Communication of Nonefficacy Benefits of New Drugs Approved on the Basis of Noninferiority Trials Alone: Cohort Study of FDA and Sponsor Communication, 2011-2017

Patient-Reported Outcome Assessments as Endpoints in Studies in Infectious Diseases

Clinician-Reported Outcome Assessments of Treatment Benefit: Report of the ISPOR Clinical Outcome Assessment Emerging Good Practices Task Force

Content validity and psychometric properties of the inFLUenza Patient-Reported Outcome Plus (FLU-PRO Plus©) instrument in patients with COVID-19

Perspectives of US Adults on Antimicrobial Trials With Noninferiority Designs

Informed Consent to Study Purpose in Randomized Clinical Trials of Antibiotics, 1991 Through 2011

Impact of respiratory syncytial virus disease on quality of life in adults aged ≥50 years: A qualitative patient experience cross‐sectional study

Regulating Antibiotics in an Era of Resistance: The Historical Basis and Continued Need for Adequate and Well-Controlled Investigations

Factor Analysis in Distinguishing Coronavirus Disease 2019 From Other Influenza-like Illness Using a Validated Patient-Reported Outcome Instrument FLU-PRO Plus: A Prospective Real-world Cohort Study

Using the Influenza Patient-reported Outcome (FLU-PRO) diary to evaluate symptoms of influenza viral infection in a healthy human challenge model

A Comparative Assessment of Approvals and Discontinuations of Systemic Antibiotics and Other Therapeutic Areas

External Validation of Difficult-to-Treat Resistance Prevalence and Mortality Risk in Gram-Negative Bloodstream Infection Using Electronic Health Record Data From 140 US Hospitals

Understanding the life experience of Barth syndrome from the perspective of adults: a qualitative one-on-one interview study

Immune and behavioral correlates of protection against symptomatic post-vaccination SARS-CoV-2 infection

Quality of life of HIV-negative, previously healthy individuals following cryptococcal meningoencephalitis

Suchergebnisse filtern